Home R&D Page 3

R&D

Subcutaneous therapy for chronic inflammatory demyelinating polyneuropathy

Green light to gemtuzumab ozogamicin for acute myeloid leukemia

Gene therapy for transfusion-dependent β-thalassemia

Positive top-line data from the STORM study on selinexor in patients...

Results of Phase 2a trial on safeproxalap for dry eye disease

Alnylam aligns with FDA for accelerated development of lumasiran in the...

New intermediate data in mycosis fungoides from a phase 1 study...

Virtual trial

Industry embraces the virtual trial platforms

A Global Commission to accelerate diagnosis in rare diseases

Phase 2a clinical study on Molgradex for the treatment of NTM...

1234...16Page 3 of 16
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151